Evanthia Gouveri

654 total citations
35 papers, 426 citations indexed

About

Evanthia Gouveri is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, Evanthia Gouveri has authored 35 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Physiology and 10 papers in Surgery. Recurrent topics in Evanthia Gouveri's work include Diabetes Treatment and Management (8 papers), Diabetic Foot Ulcer Assessment and Management (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Evanthia Gouveri is often cited by papers focused on Diabetes Treatment and Management (8 papers), Diabetic Foot Ulcer Assessment and Management (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Evanthia Gouveri collaborates with scholars based in Greece, Serbia and Romania. Evanthia Gouveri's co-authors include Νικόλαος Παπάνας, Efstratios Maltezos, Apostolos Hatzitolios, V. Danielides, Haralampos Gouveris, Djordje S. Popovic, Fotios Drakopanagiotakis, Anca Pantea Stoian, Péter Kempler and Emmanuel A. Andreadis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Metabolism and Diabetes Research and Clinical Practice.

In The Last Decade

Evanthia Gouveri

27 papers receiving 415 citations

Peers

Evanthia Gouveri

EDM

PHYSI

EPIDE

Arif Yönem Türkiye

Sarah Casey Australia

Barış Çakır Türkiye

Stefan Keslacy United States

Tae Seo Sohn South Korea

Magdalena Nowaczewska Poland

Washington Luiz Silva Gonçalves Brazil

Percy Chiu United States

Luana Beatriz Vitoretti Brazil

Aisling Ryan Ireland

Arif Yönem Türkiye

Evanthia Gouveri

162 ×1.0

EDM

79 ×0.8

116 ×1.5

PHYSI

59 ×0.8

162 ×2.4

EPIDE

Citations per year, relative to Evanthia Gouveri Evanthia Gouveri (= 1×) peers Arif Yönem

Countries citing papers authored by Evanthia Gouveri

Since Specialization

Citations

This map shows the geographic impact of Evanthia Gouveri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evanthia Gouveri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evanthia Gouveri more than expected).

Fields of papers citing papers by Evanthia Gouveri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evanthia Gouveri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evanthia Gouveri. The network helps show where Evanthia Gouveri may publish in the future.

Co-authorship network of co-authors of Evanthia Gouveri

This figure shows the co-authorship network connecting the top 25 collaborators of Evanthia Gouveri. A scholar is included among the top collaborators of Evanthia Gouveri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evanthia Gouveri. Evanthia Gouveri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gouveri, Evanthia, et al.. (2025). The Therapeutic Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Neuropathy. Experimental and Clinical Endocrinology & Diabetes. 133(8). 425–436.

Gouveri, Evanthia, et al.. (2025). GLP-1 Receptor Agonists, DPP-4 Inhibitors and the Skin—Diabetes Meets Dermatology: A Brief Narrative Review. Advances in Therapy. 42(8). 3621–3633.

Gouveri, Evanthia, et al.. (2025). The Therapeutic Potential of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Peripheral Neuropathy. Diabetes Therapy. 16(6). 1077–1105. 4 indexed citations

Gouveri, Evanthia, et al.. (2025). The Potential of Antidiabetic Medications in the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Subjects with Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 133(6). 327–339. 1 indexed citations

Gouveri, Evanthia, et al.. (2025). The Role of Inflammation in the Pathogenesis of Diabetic Peripheral Neuropathy: New Lessons from Experimental Studies and Clinical Implications. Diabetes Therapy. 16(3). 371–411. 1 indexed citations

Gouveri, Evanthia, et al.. (2025). Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review. Advances in Therapy. 42(8). 3606–3620. 2 indexed citations

Domali, Ekaterini, Christos Chatzakis, Chrysoula Margioula‐Siarkou, et al.. (2025). Metformin for Treating Gestational Diabetes: What Have We Learned During the Last Two Decades? A Systematic Review. Life. 15(1). 130–130.

Gouveri, Evanthia, et al.. (2025). GLP-1 receptor agonists and sarcopenia: Weight loss at a cost? A brief narrative review. Diabetes Research and Clinical Practice. 229. 112924–112924. 3 indexed citations

Gouveri, Evanthia, et al.. (2025). To Train or not to Train: Exercise in Diabetic Foot Ulceration. A Brief Narrative Review. The International Journal of Lower Extremity Wounds. 2173606590–2173606590.

10.

Gouveri, Evanthia, et al.. (2024). Intentional Insulin Overdose and Depression in Subjects with and Without Diabetes Mellitus: A Commentary. Diabetes Therapy. 15(9). 1845–1854. 1 indexed citations

11.

Bartziokas, Κonstantinos, Andriana Ι. Papaioannou, Fotios Drakopanagiotakis, et al.. (2024). Unraveling the Link between Ιnsulin Resistance and Bronchial Asthma. Biomedicines. 12(2). 437–437. 10 indexed citations

12.

Παπάνας, Νικόλαος, et al.. (2024). Diabetic Foot and Work Outcomes: A Review. The International Journal of Lower Extremity Wounds. 2163489447–2163489447. 2 indexed citations

13.

Nena, Evangelia, et al.. (2024). Obstructive Sleep Apnoea and Type 1 Diabetes Mellitus: A Neglected Relationship?. Experimental and Clinical Endocrinology & Diabetes. 133(1). 40–50.

14.

Gouveri, Evanthia, et al.. (2024). The role of novel inflammation-associated biomarkers in diabetic peripheral neuropathy. SHILAP Revista de lepidopterología. 24. 100328–100328. 3 indexed citations

15.

Gouveri, Evanthia & Νικόλαος Παπάνας. (2023). Τhe Endless Beauty of Metformin: Does It Also Protect from Skin Aging? A Narrative Review. Advances in Therapy. 40(4). 1347–1356. 7 indexed citations

16.

Gouveri, Evanthia, Djordje S. Popovic, & Νικόλαος Παπάνας. (2023). Potential New Therapeutic Implications of Semaglutide: New Colours of the Rainbow?. Diabetes Therapy. 15(1). 13–18. 10 indexed citations

17.

Gouveri, Evanthia & Νικόλαος Παπάνας. (2022). The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review. Diabetes Therapy. 13(5). 931–952. 12 indexed citations

18.

Gouveri, Evanthia, Paschalis Steiropoulos, & Νικόλαος Παπάνας. (2022). Does Obstructive Sleep Apnoea Syndrome Influence the Development and Treatment of Diabetic Foot? A Brief Narrative Review. The International Journal of Lower Extremity Wounds. 24(2). 294–298. 1 indexed citations

19.

Şerban, Dragoş, Νικόλαος Παπάνας, Ana Maria Dascălu, et al.. (2021). Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic Targets. The International Journal of Lower Extremity Wounds. 23(2). 205–216. 44 indexed citations

20.

Gouveri, Evanthia & Νικόλαος Παπάνας. (2021). Olfactory Dysfunction: A Complication of Diabetes or a Factor That Complicates Glucose Metabolism? A Narrative Review. Journal of Clinical Medicine. 10(23). 5637–5637. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact